HSV-2

Approximately 1 in 6 Americans (16.2 percent) between the ages of 14 and 49 is infected with herpes simplex virus type 2, according to a national health survey released March 9 by the Centers for Disease Control and Prevention.

LEIDEN, Netherlands — Dutch biopharmaceutical company Crucell announced March 8 that Jerald C. Sadoff was appointed chief medical officer will be a member of its management committee.

HIV

A seven-valent pneumococcal conjugate vaccine can protect adults with HIV against recurrent pneumococcal infection, according to research published in the March 4 issue of the New England Journal of Medicine.

DNA

Cyto Pulse Sciences announced approval from the Swedish Medical Products Agency to conduct a phase I clinical trial evaluating an HIV/DNA vaccine in collaboration with the Karolinska Institutet and the Swedish Institute for Infectious Disease Control.

HIV

For the first time researchers from the U.S. and abroad have shown that a single-dose HIV DNA vaccine can induce a long-lasting HIV-specific immune response in nonhuman primates.

HIV

The head of an association that represents Canada's HIV researchers is criticizing a federal government decision to scrap plans for an $83.5 million facility that would manufacture potential vaccines.

Hepetitis B

AltraVax Inc. has acquired a vaccine development technology package that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

HIV

WASHINGTON — A company using genetically engineered versions of the AIDS virus says its unusual approach is getting some results, both for treating and perhaps as a vaccine against HIV.

National Institute of Allergy and Infectious Diseases

WASHINGTON — An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported Feb. 18.

HIV

ATLANTA — GeoVax Labs, a biopharmaceutical company that develops vaccines for diseases caused by HIV and other infectious agents, announced the appointment of a vice president of research and development.

HIV

PHILADELPHIA — Researchers from Thomas Jefferson University are one step closer to developing a vaccine against AIDS, the school announced Dec. 14.

HIV

Researchers have identified the cause of a major hurdle in efforts to develop an AIDS vaccine, according to a report Dec. 18 in HealthDay News.

HIV

Kampala, Uganda — Fewer women compared to men are willing to participate in trials for a potential HIV/Aids vaccine, researchers revealed Dec. 15.

HIV

Researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

National Institute of Allergy and Infectious Diseases

HIV-infected adults are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine, the National Institutes of Health announced Dec. 10.

Anthony Fauci

WASHINGTON, D.C. — America’s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions.

Anders Hedegaard

KVISTGARD, Denmark — Bavarian Nordic A/S announced Nov. 30 that it expects to file a new drug submission for its third-generation smallpox vaccine, Imvamune with Health Canada in the second half of 2010.

BRAZZAVILLE, Republic of Congo — An unknown epidemic caused three deaths and affected more than 100 people in the last few days in the Republic of Congo.

HIV

World AIDS Day on Dec. 1 is intended to draw together people from around the world to raise awareness about HIV/AIDS and demonstrate international solidarity in the face of the pandemic, according to the World Health Organization.

GENEVA and SHANGHAI — According to new data in the 2009 AIDS epidemic update, new HIV infections have been reduced by 17 percent over the past eight years, the World Health Organization and United Nations Program on HIV/AIDS announced Nov. 24.

Dr. Anthony Fauci

Dr. Anthony Fauci wrote this commentary, posted Nov. 17, for msnbc.com. He is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

HIV

The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus “shell” used to transmit the therapy around the body, according to research published Nov. 16 in the Proceedings of the National Academy of Sciences.

President Bill Clinton

CHICAGO — Former President Bill Clinton says he believes there's going to be a vaccine for AIDS found before anyone discovers a cure for the disease, WBBM Radio reported.

S. Munir Alam

A study of how the most robust antibodies work to block HIV as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine, ScienceDaily reported Nov. 10.

Sandhya Vasan

Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said Oct. 22.

Dr. Anthony Fauci

The priority for AIDS virologists in coming months, a leading researcher said, is to find out exactly how the Thailand vaccine, which gave 30 percent protection against HIV, worked.